Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Alopecia × efalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Alopecia 1

Interventions

efalizumab 1 Minoxidil 1 Immunoconjugates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00746980 2016-06-14

Efalizumab in the Treatment of Alopecia, Phase II

Northwestern University

Phase 2 Withdrawn

Alopecia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡